Form 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15 (d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report: March 15, 2004

 

Date of earliest event reported: March 15, 2004

 


 

BRISTOL-MYERS SQUIBB COMPANY

(Exact name of registrant as specified in its charter)

 


 

Delaware   1-1136   22-079-0350

(State or other jurisdiction

of incorporation)

  (Commission file number)  

(IRS Employer

Identification Number)

 

345 Park Avenue

New York, NY 10154

(Address of principal executive office)

 

Registrant’s telephone number, including area code: (212) 546-4000

 



ITEM 5. OTHER EVENTS.

 

On March 15, 2004, Bristol-Myers Squibb Company issued a press release, a copy of which is attached as Exhibit 99.1.

 

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

 

(a) Financial Statements of Business to be Acquired: Not Applicable.

 

(b) Pro Forma Financial Information: Not Applicable.

 

(c) Exhibits

 

EXHIBIT NO.

 

DESCRIPTION


99.1   Press Release dated March 15, 2004 of Bristol-Myers Squibb Company.
99.2   Certain supplemental information not included in the press release.


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Bristol-Myers Squibb Company,

By:

 

/s/ SANDRA LEUNG


Name:

 

Sandra Leung

Title:

 

Secretary

 

Date: March 15, 2004


EXHIBIT INDEX

 

EXHIBIT NO.

 

DESCRIPTION


99.1   Press Release dated March 15, 2004 of Bristol-Myers Squibb Company.
99.2   Certain supplemental information not included in the press release.